Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
The New England Journal of Medicine
|
October 1, 1998
Osteogenesis imperfecta--managing brittle bones
J C Marini
Nature Medicine
|
May 6, 1999
Osteogenesis imperfecta calls for caution
J C Marini
Advances in Pediatrics
|
January 1, 1988
Osteogenesis imperfecta: comprehensive management
J C Marini
JAMA
|
April 20, 2001
Genetic risk factors for lumbar disk disease
J C Marini
Annals of Medicine
|
December 1, 1996
Ribozymes: structure, function, and potential therapy for dominant genetic disorders
G Grassi, J C Marini
The Journal of Clinical Investigation
|
January 15, 1996
Antisense oligodeoxynucleotides selectively suppress expression of the mutant alpha 2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders
Q Wang, J C Marini
Virology
|
January 1, 1977
The isolation of restriction fragments containing the att site of bacteriophage lambda
J C Marini, A Landy
Molecular Genetics and Metabolism
|
September 26, 2000
Osteogenesis imperfecta: prospects for molecular therapeutics
A Forlino, J C Marini
Nucleic Acids Research
|
October 12, 2000
Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts
P A Dawson, J C Marini
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
March 3, 1999
Evaluation of oral problems in an osteogenesis imperfecta population
A C O'Connell, J C Marini
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
The New England Journal of Medicine
|
October 1, 1998
Osteogenesis imperfecta--managing brittle bones
J C Marini
Nature Medicine
|
May 6, 1999
Osteogenesis imperfecta calls for caution
J C Marini
Advances in Pediatrics
|
January 1, 1988
Osteogenesis imperfecta: comprehensive management
J C Marini
JAMA
|
April 20, 2001
Genetic risk factors for lumbar disk disease
J C Marini
Annals of Medicine
|
December 1, 1996
Ribozymes: structure, function, and potential therapy for dominant genetic disorders
G Grassi, J C Marini
The Journal of Clinical Investigation
|
January 15, 1996
Antisense oligodeoxynucleotides selectively suppress expression of the mutant alpha 2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders
Q Wang, J C Marini
Virology
|
January 1, 1977
The isolation of restriction fragments containing the att site of bacteriophage lambda
J C Marini, A Landy
Molecular Genetics and Metabolism
|
September 26, 2000
Osteogenesis imperfecta: prospects for molecular therapeutics
A Forlino, J C Marini
Nucleic Acids Research
|
October 12, 2000
Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts
P A Dawson, J C Marini
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
March 3, 1999
Evaluation of oral problems in an osteogenesis imperfecta population
A C O'Connell, J C Marini
Page
of 8